SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

EW

Edwards Lifesciences Corporation
NYSEHealth Care

Latest close: 86.60 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 8, 2026Reported sale · Form 4Daniel J. Lippis, CVP, TAVR · $53.0KOpen the filing ↗
  2. Sep 11, 2026Reported sale · Form 4Daniel J. Lippis, CVP, TAVR · $54.2KOpen the filing ↗
  3. Aug 31, 2026Reported sale · Form 4Andrew M. Dahl, SVP, Corporate Controller · $49.5KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record2,4269 flagged findings
Reported transactions (Form 4)80since Dec 12, 2025 · and 15 other holdings
Corporate events (8-K)30since Jul 30, 2015

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model: ESPP…”
    +1 more passage from the same document
    • “…used in the Black-Scholes option pricing model: ESPP Three Months Ended March 31, 2026 2025 Risk-free interest rate 3.6 % 4.3 %…”
  • 2026-05-06merger or acquisition eventrecentOpen filing ↗
    “…notes. Unconsolidated VIEs Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power…”
    +1 more passage from the same document
    • “…the potential impact on its financial statements. The Company intends to vigorously defend itself in this litigation. On February…”
  • 2026-02-25capital return (buybacks/dividends)recentOpen filing ↗
    “…to time at specified redemption prices. As of December 31, 2025, we have not elected to redeem any of the 2018 Notes. As of December…”
    +1 more passage from the same document
    • “…share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our…”
  • 2026-02-25merger or acquisition eventrecentOpen filing ↗
    “…its investment in the VIEs, which include equity investments, options to acquire, and promissory notes. Unconsolidated VIEs Edwards…”
    +1 more passage from the same document
    • “…include equity investments, options to acquire, and promissory notes. Unconsolidated VIEs Edwards has relationships with various VIEs…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 2,426)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

2,426 filings on record, the oldest from May 15, 00.

Listing the 25 most recent filings of the 2,426 on record.

8-Ks, explained

Stress4Structure33Governance37
  • Governance11 senior executive changes2022 – 2026show all 11hide
    • Aug 28, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 8, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 4, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 30, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 25, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 8, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 10, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 17, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 26, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 15, 23GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Dec 8, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 21, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • May 5, 21GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Jul 15, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 15, 18StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Apr 30, 18StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • May 12, 17GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 23, 17StructureCompleted an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
  • Nov 28, 16StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Governance4 senior executive changes2015 – 2016show all 4hide
    • Jul 5, 16GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • May 13, 16GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Mar 17, 16GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 23, 15GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 28, 15StructureCompleted an acquisition or disposal8-K 2.01 ↗
  • Jul 30, 15GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

The record reaches back to Dec 27, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Feb 27, 12StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • Nov 10, 08StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 5, 06StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗

The full record holds 4 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 31, Dahl Andrew M. filed notice of intent to sell up to $50K.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $50K on Aug 31, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+8 more recent notices · 7 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 8, 26Sell$53KDaniel J. LippisCVP, TAVR↗
  • Sep 11, 26Sell$54KDaniel J. LippisCVP, TAVR↗
  • Aug 31, 26Sell$50KAndrew M. DahlSVP, Corporate Controller↗
  • Aug 28, 26Sell$238KAnnette BrulsCVP, EMEACLA↗
  • Aug 26, 26Sell$113KWayne MarkowitzCVP, JAPAC↗
  • Aug 26, 26Sell$106KDaveen ChopraCVP, TMTT, Surgical & IHFM↗
  • Aug 26, 26Sell$2.8MDaveen ChopraCVP, TMTT, Surgical & IHFM↗
  • Aug 11, 26Sell$57KDaniel J. LippisCVP, TAVR↗
  • Jul 30, 26Sell$13KWayne MarkowitzCVP, JAPAC↗
  • Jul 28, 26Sell$819KWayne MarkowitzCVP, JAPAC↗
  • Jul 27, 26Sell$245KBernard J ZovighianCEO↗
  • Jul 10, 26Sell$57KDaniel J. LippisCVP, TAVR↗

There are 10 more transactions in this stretch.

Stock compensation, tax and giftsshow the 18 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 8, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • Sep 14, 26Tax$48KWayne MarkowitzCVP, JAPAC↗
  • Sep 13, 26Tax$21KAndrew M. DahlSVP, Corporate Controller↗
  • Sep 11, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • Sep 11, 26Tax$35KDaveen ChopraCVP, TMTT, Surgical & IHFM↗
  • Sep 11, 26Tax$31KWayne MarkowitzCVP, JAPAC↗
  • Aug 26, 26Compensation$2.3MDaveen ChopraCVP, TMTT, Surgical & IHFM↗
  • Aug 11, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • Jul 28, 26Compensation$713KWayne MarkowitzCVP, JAPAC↗
  • Jul 27, 26Giftamount n/aBernard J ZovighianCEO↗
  • Jul 11, 26Tax$10KAnnette BrulsCVP, EMEACLA↗
  • Jul 10, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • Jul 9, 26Compensationamount n/aTheodora MistrasCVP, Chief Financial Officer↗
  • Jul 9, 26Compensationamount n/aTheodora MistrasCVP, Chief Financial Officer↗
  • Jul 7, 26Tax$36KDaniel J. LippisCVP, TAVR↗
  • Jun 30, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • May 18, 26Compensation$45KDaniel J. LippisCVP, TAVR↗
  • May 12, 26Giftamount n/aBernard J ZovighianCEO↗

The full record holds 670 transactions and goes back to May 3, 22.

Its sector and its market

Edwards Lifesciences Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Edwards Lifesciences Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Edwards Lifesciences Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
2,426 documents on file, from May 15, 2000 to Oct 8, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.